Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: KALA BIO(KALA) the EBIT is -1.802 M (+83.08%);the EPS is -0.137 (+99.81%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B83.08%
----
----
EPS
-0.136599.81%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf